Literature DB >> 27544075

Estimating the Number of Pregnant Women Infected With Zika Virus and Expected Infants With Microcephaly Following the Zika Virus Outbreak in Puerto Rico, 2016.

Sascha R Ellington1, Owen Devine2, Jeanne Bertolli3, Alma Martinez Quiñones4, Carrie K Shapiro-Mendoza3, Janice Perez-Padilla3, Brenda Rivera-Garcia4, Regina M Simeone3, Denise J Jamieson3, Miguel Valencia-Prado4, Suzanne M Gilboa3, Margaret A Honein3, Michael A Johansson3.   

Abstract

IMPORTANCE: Zika virus (ZIKV) infection during pregnancy is a cause of congenital microcephaly and severe fetal brain defects, and it has been associated with other adverse pregnancy and birth outcomes.
OBJECTIVE: To estimate the number of pregnant women infected with ZIKV in Puerto Rico and the number of associated congenital microcephaly cases. DESIGN, SETTING, AND PARTICIPANTS: We conducted a modeling study from April to July 2016. Using parameters derived from published reports, outcomes were modeled probabilistically using Monte Carlo simulation. We used uncertainty distributions to reflect the limited information available for parameter values. Given the high level of uncertainty in model parameters, interquartile ranges (IQRs) are presented as primary results. Outcomes were modeled for pregnant women in Puerto Rico, which currently has more confirmed ZIKV cases than any other US location. EXPOSURE: Zika virus infection in pregnant women. MAIN OUTCOMES AND MEASURES: Number of pregnant women infected with ZIKV and number of congenital microcephaly cases.
RESULTS: We estimated an IQR of 5900 to 10 300 pregnant women (median, 7800) might be infected during the initial ZIKV outbreak in Puerto Rico. Of these, an IQR of 100 to 270 infants (median, 180) may be born with microcephaly due to congenital ZIKV infection from mid-2016 to mid-2017. In the absence of a ZIKV outbreak, an IQR of 9 to 16 cases (median, 12) of congenital microcephaly are expected in Puerto Rico per year. CONCLUSIONS AND RELEVANCE: The estimate of 5900 to 10 300 pregnant women that might be infected with ZIKV provides an estimate for the number of infants that could potentially have ZIKV-associated adverse outcomes. Including baseline cases of microcephaly, we estimated that an IQR of 110 to 290 total cases of congenital microcephaly, mostly attributable to ZIKV infection, could occur from mid-2016 to mid-2017 in the absence of effective interventions. The primary limitation in this analysis is uncertainty in model parameters. Multivariate sensitivity analyses indicated that the cumulative incidence of ZIKV infection and risk of microcephaly given maternal infection in the first trimester were the primary drivers of both magnitude and uncertainty in the estimated number of microcephaly cases. Increased information on these parameters would lead to more precise estimates. Nonetheless, the results underscore the need for urgent actions being undertaken in Puerto Rico to prevent congenital ZIKV infection and prepare for affected infants.

Entities:  

Mesh:

Year:  2016        PMID: 27544075     DOI: 10.1001/jamapediatrics.2016.2974

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  19 in total

1.  Experimental Zika Virus Infection of Neotropical Primates.

Authors:  John A Vanchiere; Julio C Ruiz; Alan G Brady; Thomas J Kuehl; Lawrence E Williams; Wallace B Baze; Gregory K Wilkerson; Pramod N Nehete; Gloria B McClure; Donna L Rogers; Shannan L Rossi; Sasha R Azar; Christopher M Roundy; Scott C Weaver; Nikos Vasilakis; Joe H Simmons; Christian R Abee
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  Sources affecting knowledge and behavior responses to the Zika virus in US households with current pregnancy, intended pregnancy and a high probability of unintended pregnancy.

Authors:  Man-Pui Sally Chan; Mohsen Farhadloo; Kenneth Winneg; Kathleen Hall Jamieson; Dolores Albarracin
Journal:  J Public Health (Oxf)       Date:  2018-12-01       Impact factor: 2.341

Review 3.  Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee.

Authors:  Meagan C Fitzpatrick; Burton H Singer; Peter J Hotez; Alison P Galvani
Journal:  Lancet       Date:  2017-06-29       Impact factor: 79.321

4.  Reducing Unintended Pregnancies as a Strategy to Avert Zika-Related Microcephaly Births in the United States: A Simulation Study.

Authors:  Katherine A Ahrens; Jennifer A Hutcheon; Loretta Gavin; Susan Moskosky
Journal:  Matern Child Health J       Date:  2017-05

Review 5.  Quantifying Zika: Advancing the Epidemiology of Zika With Quantitative Models.

Authors:  Lindsay T Keegan; Justin Lessler; Michael A Johansson
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

6.  Evaluating Vaccination Strategies for Zika Virus in the Americas.

Authors:  David P Durham; Meagan C Fitzpatrick; Martial L Ndeffo-Mbah; Alyssa S Parpia; Nelson L Michael; Alison P Galvani
Journal:  Ann Intern Med       Date:  2018-04-03       Impact factor: 25.391

7.  Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016.

Authors:  Rui Li; Katharine B Simmons; Jeanne Bertolli; Brenda Rivera-Garcia; Shanna Cox; Lisa Romero; Lisa M Koonin; Miguel Valencia-Prado; Nabal Bracero; Denise J Jamieson; Wanda Barfield; Cynthia A Moore; Cara T Mai; Lauren C Korhonen; Meghan T Frey; Janice Perez-Padilla; Ricardo Torres-Muñoz; Scott D Grosse
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883

Review 8.  Microcephaly Prevalence in Infants Born to Zika Virus-Infected Women: A Systematic Review and Meta-Analysis.

Authors:  Antonio Victor Campos Coelho; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2017-08-05       Impact factor: 5.923

9.  A comparison study of Zika virus outbreaks in French Polynesia, Colombia and the State of Bahia in Brazil.

Authors:  Daihai He; Daozhou Gao; Yijun Lou; Shi Zhao; Shigui Ruan
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

10.  The Zika epidemic and abortion in Latin America: a scoping review.

Authors:  Mabel Carabali; Nichole Austin; Nicholas B King; Jay S Kaufman
Journal:  Glob Health Res Policy       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.